{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:57:18Z","timestamp":1784249838520,"version":"3.55.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","award":["0072\/DIA\/2017\/46"],"award-info":[{"award-number":["0072\/DIA\/2017\/46"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12933-019-0918-x","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T20:01:44Z","timestamp":1567195304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":146,"title":["Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3513-141X","authenticated-orcid":false,"given":"Justyna","family":"Pordzik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Jakubik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Jarosz-Popek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Wicik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceren","family":"Eyileten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta M.","family":"Siller-Matula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Czajka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Postula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"918_CR1","unstructured":"IDF Diabetes Atlas 6th Edition. Brussels: International Diabetes Federation; 2013. https:\/\/www.idf.org\/e-library\/epidemiology-research\/diabetes-atlas\/19-atlas-6th-edition.html . Accessed 12th December 2018."},{"issue":"3","key":"918_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40842-016-0039-3","volume":"18","author":"PZ Zimmet","year":"2017","unstructured":"Zimmet PZ. Diabetes and its drivers: the largest epidemic in human history? Clin Diabetes Endocrinol. 2017;18(3):1. https:\/\/doi.org\/10.1186\/s40842-016-0039-3 .","journal-title":"Clin Diabetes Endocrinol"},{"issue":"9467","key":"918_CR3","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/s0140-6736(05)61032-x","volume":"365","author":"M Stumvoll","year":"2005","unstructured":"Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365(9467):1333\u201346. https:\/\/doi.org\/10.1016\/s0140-6736(05)61032-x .","journal-title":"Lancet"},{"issue":"1","key":"918_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S2213-8587(13)70112-8","volume":"2","author":"PZ Zimmet","year":"2014","unstructured":"Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014;2(1):56\u201364. https:\/\/doi.org\/10.1016\/S2213-8587(13)70112-8 .","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"918_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1586\/14737167.2015.1024661","volume":"15","author":"V Vaidya","year":"2015","unstructured":"Vaidya V, Gangan N, Sheehan J. Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15(3):487\u201397. https:\/\/doi.org\/10.1586\/14737167.2015.1024661 .","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"11","key":"918_CR6","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1182\/blood-2016-07-692673","volume":"129","author":"MD Wu","year":"2017","unstructured":"Wu MD, Atkinson TM, Lindner JR. Platelets and von Willebrand factor in atherogenesis. Blood. 2017;129(11):1415\u20139. https:\/\/doi.org\/10.1182\/blood-2016-07-692673 .","journal-title":"Blood"},{"key":"918_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3132\/dvdr.2008.023","volume":"5","author":"A Natarajan","year":"2008","unstructured":"Natarajan A, Zaman AG, Marshall SM. Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents. Diabetes Vasc Dis Res. 2008;5:138\u201344. https:\/\/doi.org\/10.3132\/dvdr.2008.023 .","journal-title":"Diabetes Vasc Dis Res"},{"key":"918_CR8","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/j.1538-7836.2004.00836.x","volume":"2","author":"P Ferroni","year":"2004","unstructured":"Ferroni P, Basili S, Falco A, et al. Platelet activation in type 2 diabetes mellitus. J Thromb Haemost. 2004;2:1282\u201391. https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00836.x .","journal-title":"J Thromb Haemost"},{"issue":"5091","key":"918_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87\u201391.","journal-title":"Science"},{"key":"918_CR10","doi-asserted-by":"publisher","first-page":"6494795","DOI":"10.1155\/2017\/6494795","volume":"2017","author":"C Xia","year":"2017","unstructured":"Xia C, Rao X, Zhong J. Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation. J Diabetes Res. 2017;2017:6494795. https:\/\/doi.org\/10.1155\/2017\/6494795 .","journal-title":"J Diabetes Res"},{"key":"918_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1160\/TH06-11-0628","volume":"98","author":"B Nagy Jr","year":"2007","unstructured":"Nagy B Jr, Csongr\u00e1di E, Bhattoa HP, et al. Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus. Thromb Haemost. 2007;98:186\u201391.","journal-title":"Thromb Haemost"},{"issue":"11","key":"918_CR12","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1111\/j.1538-7836.2011.04482.x","volume":"9","author":"M Postula","year":"2011","unstructured":"Postula M, Kaplon-Cieslicka A, Rosiak M, Kondracka A, Serafin A, Filipiak KJ, Czlonkowski A, Opolski G, Janicki PK. Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes. J Thromb Haemost. 2011;9(11):2291\u2013301. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04482.x .","journal-title":"J Thromb Haemost"},{"issue":"2","key":"918_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-0037-1607432","volume":"44","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Davis RP, Jenne CN. Platelets as modulators of inflammation. Semin Thromb Hemost. 2018;44(2):91\u2013101. https:\/\/doi.org\/10.1055\/s-0037-1607432 .","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"918_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1570161115666170126130309","volume":"15","author":"N Cortez-Espinosa","year":"2017","unstructured":"Cortez-Espinosa N, Mayoral LP, Perez-Campos E, Cabrera Fuentes HA, Mayoral EP, Mart\u00ednez-Cruz R, Canseco SP, Andrade GM, Cruz MM, Velasco IG, Cruz PH. Platelets and platelet-derived microvesicles as immune effectors in type 2 diabetes. Curr Vasc Pharmacol. 2017;15(3):207\u201317. https:\/\/doi.org\/10.2174\/1570161115666170126130309 .","journal-title":"Curr Vasc Pharmacol"},{"issue":"14","key":"918_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12014-017-9146-0","volume":"8","author":"CT Nielsen","year":"2017","unstructured":"Nielsen CT, \u00d8stergaard O, Rasmussen NS, Jacobsen S, Heegaard NHH. A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus. Clin Proteom. 2017;8(14):11. https:\/\/doi.org\/10.1186\/s12014-017-9146-0 .","journal-title":"Clin Proteom"},{"key":"918_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1160\/TH12-03-0211","volume":"108","author":"S Dangwal","year":"2012","unstructured":"Dangwal S, Thum T. MicroRNAs in platelet biogenesis and function. Thromb Haemost. 2012;108:599\u2013604. https:\/\/doi.org\/10.1160\/TH12-03-0211 .","journal-title":"Thromb Haemost"},{"issue":"12","key":"918_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/cells7120249","volume":"7","author":"C Eyileten","year":"2018","unstructured":"Eyileten C, Wicik Z, De Rosa S, Mirowska-Guzel D, Soplinska A, Indolfi C, Jastrzebska-Kurkowska I, Czlonkowska A, Postula M. MicroRNAs as diagnostic and prognostic biomarkers in ischemic stroke\u2014a comprehensive review and bioinformatic analysis. Cells. 2018;7(12):249. https:\/\/doi.org\/10.3390\/cells7120249 .","journal-title":"Cells"},{"key":"918_CR18","first-page":"292","volume":"11","author":"Y Wang","year":"2009","unstructured":"Wang Y, Russell I, Chen C. MicroRNA and stem cell regulation. CurrOpin Mol Ther. 2009;11:292\u20138.","journal-title":"CurrOpin Mol Ther"},{"issue":"4","key":"918_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/CIRCRESAHA.116.303549","volume":"116","author":"T Thum","year":"2015","unstructured":"Thum T, Condorelli G. Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circ Res. 2015;116(4):751\u201362. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303549 .","journal-title":"Circ Res"},{"issue":"11","key":"918_CR20","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","volume":"56","author":"JA Weber","year":"2010","unstructured":"Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56(11):1733\u201341. https:\/\/doi.org\/10.1373\/clinchem.2010.147405 .","journal-title":"Clin Chem"},{"key":"918_CR21","doi-asserted-by":"publisher","first-page":"456569","DOI":"10.1155\/2014\/456569","volume":"2014","author":"JL Choi","year":"2014","unstructured":"Choi JL, Li S, Han JY. Platelet function tests: a review of progresses in clinical application. Biomed Res Int. 2014;2014:456569. https:\/\/doi.org\/10.1155\/2014\/456569 .","journal-title":"Biomed Res Int"},{"issue":"1","key":"918_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nprot.2008.216","volume":"4","author":"S Streit","year":"2009","unstructured":"Streit S, Michalski CW, Erkan M, Kleeff J, Friess H. Northern blot analysis for detection and quantification of RNA in pancreatic cancer cells and tissues. Nat Protoc. 2009;4(1):37\u201343. https:\/\/doi.org\/10.1038\/nprot.2008.216 .","journal-title":"Nat Protoc"},{"issue":"2","key":"918_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nprot.2007.528","volume":"3","author":"E V\u00e1rallyay","year":"2008","unstructured":"V\u00e1rallyay E, Burgy\u00e1n J, Havelda Z. MicroRNA detection by northern blotting using locked nucleic acid probes. Nat Protoc. 2008;3(2):190\u20136. https:\/\/doi.org\/10.1038\/nprot.2007.528 .","journal-title":"Nat Protoc"},{"issue":"9","key":"918_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fendo.2018.00074","volume":"20","author":"J Pordzik","year":"2018","unstructured":"Pordzik J, Pisarz K, De Rosa S, Jones AD, Eyileten C, Indolfi C, Malek L, Postula M. The potential role of platelet-related microRNAs in the development of cardiovascular events in high-risk populations, including diabetic patients: a review. Front Endocrinol. 2018;20(9):74. https:\/\/doi.org\/10.3389\/fendo.2018.00074 .","journal-title":"Front Endocrinol"},{"issue":"6","key":"918_CR25","doi-asserted-by":"publisher","first-page":"25540","DOI":"10.1038\/srep25540","volume":"9","author":"D Ferraro","year":"2016","unstructured":"Ferraro D, Champ J, Teste B, Serra M, Malaquin L, Viovy JL, de Cremoux P, Descroix S. Microfluidic platform combining droplets and magnetic tweezers: application to HER2 expression in cancer diagnosis. Sci Rep. 2016;9(6):25540. https:\/\/doi.org\/10.1038\/srep25540 .","journal-title":"Sci Rep"},{"issue":"4","key":"918_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/0471142727.mb0417s103","volume":"4","author":"S Eminaga","year":"2013","unstructured":"Eminaga S, Christodoulou DC, Vigneault F, Church GM, Seidman JG. Quantification of microRNA expression with next-generation sequencing. Curr Protoc Mol Biol. 2013;4(4):17. https:\/\/doi.org\/10.1002\/0471142727.mb0417s103 .","journal-title":"Curr Protoc Mol Biol"},{"issue":"5","key":"918_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/wrna.1120","volume":"3","author":"P Chugh","year":"2012","unstructured":"Chugh P, Dittmer DP. Potential pitfalls in microRNA profiling. Wiley Interdiscip Rev RNA. 2012;3(5):601\u201316. https:\/\/doi.org\/10.1002\/wrna.1120 .","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"918_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-3-0348-0955-9_6","volume":"106","author":"S De Rosa","year":"2015","unstructured":"De Rosa S, Indolfi C. Circulating microRNAs as biomarkers in cardiovascular diseases. Exp Suppl. 2015;106:139\u201349. https:\/\/doi.org\/10.1007\/978-3-0348-0955-9_6 .","journal-title":"Exp Suppl"},{"issue":"1","key":"918_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00592-010-0226-0","volume":"48","author":"L Kong","year":"2011","unstructured":"Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y, Dong Q, Pang Z, Guan Q, Gao L, Zhao J, Zhao L. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2011;48(1):61\u20139. https:\/\/doi.org\/10.1007\/s00592-010-0226-0 .","journal-title":"Acta Diabetol"},{"issue":"12","key":"918_CR30","doi-asserted-by":"publisher","first-page":"E2271","DOI":"10.1210\/jc.2012-1996","volume":"97","author":"DS Karolina","year":"2012","unstructured":"Karolina DS, Tavintharan S, Armugam A, Sepramaniam S, Pek SL, Wong MT, Lim SC, Sum CF, Jeyaseelan K. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab. 2012;97(12):E2271\u20136. https:\/\/doi.org\/10.1210\/jc.2012-1996 .","journal-title":"J Clin Endocrinol Metab"},{"key":"918_CR31","doi-asserted-by":"publisher","first-page":"761617","DOI":"10.1155\/2013\/761617","volume":"2013","author":"T Zhang","year":"2013","unstructured":"Zhang T, Lv C, Li L, Chen S, Liu S, Wang C, Su B. Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals. Biomed Res Int. 2013;2013:761617. https:\/\/doi.org\/10.1155\/2013\/761617 .","journal-title":"Biomed Res Int"},{"issue":"6","key":"918_CR32","doi-asserted-by":"publisher","first-page":"10567","DOI":"10.3390\/ijms150610567","volume":"15","author":"Y Liu","year":"2014","unstructured":"Liu Y, Gao G, Yang C, Zhou K, Shen B, Liang H, Jiang X. The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci. 2014;15(6):10567\u201377. https:\/\/doi.org\/10.3390\/ijms150610567 .","journal-title":"Int J Mol Sci"},{"issue":"4","key":"918_CR33","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/13813455.2017.1396349","volume":"124","author":"S Ghorbani","year":"2018","unstructured":"Ghorbani S, Mahdavi R, Alipoor B, Panahi G, Nasli Esfahani E, Razi F, Taghikhani M, Meshkani R. Decreased serum microRNA-21 level is associated with obesity in healthy and type 2 diabetic subjects. Arch Physiol Biochem. 2018;124(4):300\u20135. https:\/\/doi.org\/10.1080\/13813455.2017.1396349 .","journal-title":"Arch Physiol Biochem"},{"issue":"2","key":"918_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/jcm7020012","volume":"7","author":"HA Al-Muhtaresh","year":"2018","unstructured":"Al-Muhtaresh HA, Al-Kafaji G. Evaluation of two-diabetes related microRNAs suitability as earlier blood biomarkers for detecting prediabetes and type 2 diabetes mellitus. J Clin Med. 2018;7(2):12. https:\/\/doi.org\/10.3390\/jcm7020012 .","journal-title":"J Clin Med"},{"issue":"12","key":"918_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.omtn.2018.05.002","volume":"7","author":"R Jim\u00e9nez-Lucena","year":"2018","unstructured":"Jim\u00e9nez-Lucena R, Rangel-Z\u00fa\u00f1iga OA, Alcal\u00e1-D\u00edaz JF, L\u00f3pez-Moreno J, Roncero-Ramos I, Molina-Abril H, Yubero-Serrano EM, Caballero-Villarraso J, Delgado-Lista J, Casta\u00f1o JP, Ordov\u00e1s JM, P\u00e9rez-Martinez P, Camargo A, L\u00f3pez-Miranda J. Circulating miRNAs as predictive biomarkers of type 2 diabetes mellitus development in coronary heart disease patients from the CORDIOPREV study. Mol Ther Nucleic Acids. 2018;7(12):146\u201357. https:\/\/doi.org\/10.1016\/j.omtn.2018.05.002 .","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"918_CR36","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","volume":"107","author":"A Zampetaki","year":"2010","unstructured":"Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, Shah A, Willeit J, Mayr M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107(6):810\u20137. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.226357 .","journal-title":"Circ Res"},{"issue":"1\u20132","key":"918_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbrc.2015.05.017","volume":"463","author":"T Zhang","year":"2015","unstructured":"Zhang T, Li L, Shang Q, Lv C, Wang C, Su B. Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals. Biochem Biophys Res Commun. 2015;463(1\u20132):60\u20133. https:\/\/doi.org\/10.1016\/j.bbrc.2015.05.017 .","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"918_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11892-013-0375-y","volume":"13","author":"E Lontchi-Yimagou","year":"2013","unstructured":"Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Curr Diab Rep. 2013;13(3):435\u201344. https:\/\/doi.org\/10.1007\/s11892-013-0375-y .","journal-title":"Curr Diab Rep"},{"issue":"6","key":"918_CR39","doi-asserted-by":"crossref","first-page":"414","DOI":"10.20452\/pamw.2880","volume":"125","author":"A Kap\u0142on-Cie\u015blicka","year":"2015","unstructured":"Kap\u0142on-Cie\u015blicka A, Postu\u0142a M, Rosiak M, Peller M, Kondracka A, Serafin A, Trzepla E, Opolski G, Filipiak KJ. Association of adipokines and inflammatory markers with lipid control in type 2 diabetes. Pol Arch Med Wewn. 2015;125(6):414\u201323.","journal-title":"Pol Arch Med Wewn"},{"issue":"4","key":"918_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/09537104.2015.1109071","volume":"27","author":"M Postula","year":"2016","unstructured":"Postula M, Janicki PK, Eyileten C, Rosiak M, Kaplon-Cieslicka A, Sugino S, Wilimski R, Kosior DA, Opolski G, Filipiak KJ, Mirowska-Guzel D. Next-generation re-sequencing of genes involved in increased platelet reactivity in diabetic patients on acetylsalicylic acid. Platelets. 2016;27(4):357\u201364. https:\/\/doi.org\/10.3109\/09537104.2015.1109071 .","journal-title":"Platelets"},{"issue":"5","key":"918_CR41","doi-asserted-by":"publisher","first-page":"594","DOI":"10.21037\/cdt.2018.05.09","volume":"8","author":"JR Rivas Rios","year":"2018","unstructured":"Rivas Rios JR, Franchi F, Rollini F, Angiolillo DJ. Diabetes and antiplatelet therapy: from bench to bedside. Cardiovasc Diagn Ther. 2018;8(5):594\u2013609. https:\/\/doi.org\/10.21037\/cdt.2018.05.09 .","journal-title":"Cardiovasc Diagn Ther"},{"issue":"2","key":"918_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/09537100500260865","volume":"17","author":"DC Calverley","year":"2006","unstructured":"Calverley DC, Baldermann LV, Moran K, Chen NN, McFann K. Platelet FcgammaRIIA expression is associated with the alpha2 integrin C807T gene polymorphism in type 2 diabetes. Platelets. 2006;17(2):78\u201383. https:\/\/doi.org\/10.1080\/09537100500260865 .","journal-title":"Platelets"},{"issue":"2","key":"918_CR43","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0021-9150(02)00179-X","volume":"164","author":"DC Calverley","year":"2002","unstructured":"Calverley DC, Brass E, Hacker MR, Tsao-Wei DD, Espina BM, Pullarkat VA, Hodis HN, Groshen S. Potential role of platelet FcgammaRIIA in collagen-mediated platelet activation associated with atherothrombosis. Atherosclerosis. 2002;164(2):261\u20137.","journal-title":"Atherosclerosis"},{"issue":"1\u20132","key":"918_CR44","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11010-011-0727-3","volume":"351","author":"M Balasubramanyam","year":"2011","unstructured":"Balasubramanyam M, Aravind S, Gokulakrishnan K, Prabu P, Sathishkumar C, Ranjani H, Mohan V. Impaired miR-146a expression links subclinical inflammation and insulin resistance in type 2 diabetes. Mol Cell Biochem. 2011;351(1\u20132):197\u2013205. https:\/\/doi.org\/10.1007\/s11010-011-0727-3 .","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"918_CR45","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00592-015-0733-0","volume":"52","author":"M Luo","year":"2015","unstructured":"Luo M, Li R, Deng X, Ren M, Chen N, Zeng M, Yan K, Xia J, Liu F, Ma W, Yang Y, Wan Q, Wu J. Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes. Acta Diabetol. 2015;52(5):943\u20139. https:\/\/doi.org\/10.1007\/s00592-015-0733-0 .","journal-title":"Acta Diabetol"},{"issue":"5","key":"918_CR46","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.cmet.2012.10.009","volume":"16","author":"T Mahdi","year":"2012","unstructured":"Mahdi T, H\u00e4nzelmann S, Salehi A, Muhammed SJ, Reinbothe TM, Tang Y, Axelsson AS, Zhou Y, Jing X, Almgren P, Krus U, Taneera J, Blom AM, Lyssenko V, Esguerra JL, Hansson O, Eliasson L, Derry J, Zhang E, Wollheim CB, Groop L, Renstr\u00f6m E, Rosengren AH. Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes. Cell Metab. 2012;16(5):625\u201333. https:\/\/doi.org\/10.1016\/j.cmet.2012.10.009 .","journal-title":"Cell Metab"},{"issue":"34","key":"918_CR47","doi-asserted-by":"publisher","first-page":"35372","DOI":"10.18632\/oncotarget.6164","volume":"6","author":"F Olivieri","year":"2015","unstructured":"Olivieri F, Spazzafumo L, Bonaf\u00e8 M, Recchioni R, Prattichizzo F, Marcheselli F, Micolucci L, Mens\u00e0 E, Giuliani A, Santini G, Gobbi M, Lazzarini R, Boemi M, Testa R, Antonicelli R, Procopio AD, Bonfigli AR. MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications. Oncotarget. 2015;6(34):35372\u201382. https:\/\/doi.org\/10.18632\/oncotarget.6164 .","journal-title":"Oncotarget"},{"issue":"1","key":"918_CR48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12933-017-0600-0","volume":"16","author":"A Giannella","year":"2017","unstructured":"Giannella A, Radu CM, Franco L, Campello E, Simioni P, Avogaro A, de Kreutzenberg SV, Ceolotto G. Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance. Cardiovasc Diabetol. 2017;16(1):118. https:\/\/doi.org\/10.1186\/s12933-017-0600-0 .","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"918_CR49","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/ATVBAHA.115.306094","volume":"36","author":"M Witkowski","year":"2016","unstructured":"Witkowski M, Weithauser A, Tabaraie T, Steffens D, Kr\u00e4nkel N, Witkowski M, Stratmann B, Tschoepe D, Landmesser U, Rauch-Kroehnert U. Micro-RNA-126 reduces the blood thrombogenicity in diabetes mellitus via targeting of tissue factor. Arterioscler Thromb Vasc Biol. 2016;36(6):1263\u201371. https:\/\/doi.org\/10.1161\/ATVBAHA.115.306094 .","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"918_CR50","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1161\/ATVBAHA.110.211706","volume":"30","author":"TA Harris","year":"2010","unstructured":"Harris TA, Yamakuchi M, Kondo M, Oettgen P, Lowenstein CJ. Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells. Arterioscler Thromb Vasc Biol. 2010;30(10):1990\u20137. https:\/\/doi.org\/10.1161\/ATVBAHA.110.211706 .","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"918_CR51","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s12291-015-0516-y","volume":"31","author":"R Dhananjayan","year":"2016","unstructured":"Dhananjayan R, Koundinya KS, Malati T, Kutala VK. Endothelial dysfunction in type 2 diabetes mellitus. Indian J Clin Biochem. 2016;31(4):372\u20139. https:\/\/doi.org\/10.1007\/s12291-015-0516-y .","journal-title":"Indian J Clin Biochem"},{"issue":"1","key":"918_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","volume":"17","author":"R Kaur","year":"2018","unstructured":"Kaur R, Kaur M, Singh J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol. 2018;17(1):121. https:\/\/doi.org\/10.1186\/s12933-018-0763-3 .","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"918_CR53","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3390\/ijms17111853","volume":"17","author":"R Jagadapillai","year":"2016","unstructured":"Jagadapillai R, Rane MJ, Lin X, Roberts AM, Hoyle GW, Cai L, Gozal E. Diabetic microvascular disease and pulmonary fibrosis: the contribution of platelets and systemic inflammation. Int J Mol Sci. 2016;17(11):1853. https:\/\/doi.org\/10.3390\/ijms17111853 .","journal-title":"Int J Mol Sci"},{"issue":"15","key":"918_CR54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12933-016-0367-8","volume":"22","author":"F Jansen","year":"2016","unstructured":"Jansen F, Wang H, Przybilla D, Franklin BS, Dolf A, Pfeifer P, Schmitz T, Flender A, Endl E, Nickenig G, Werner N. Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus. Cardiovasc Diabetol. 2016;22(15):49. https:\/\/doi.org\/10.1186\/s12933-016-0367-8 .","journal-title":"Cardiovasc Diabetol"},{"issue":"38","key":"918_CR55","doi-asserted-by":"publisher","first-page":"63038","DOI":"10.18632\/oncotarget.18593","volume":"8","author":"X Deng","year":"2017","unstructured":"Deng X, Liu Y, Luo M, Wu J, Ma R, Wan Q, Wu J. Circulating miRNA-24 and its target YKL-40 as potential biomarkers in patients with coronary heart disease and type 2 diabetes mellitus. Oncotarget. 2017;8(38):63038\u201346. https:\/\/doi.org\/10.18632\/oncotarget.18593 .","journal-title":"Oncotarget"},{"issue":"2","key":"918_CR56","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/09674845.2017.1402404","volume":"75","author":"KS Amr","year":"2018","unstructured":"Amr KS, Abdelmawgoud H, Ali ZY, Shehata S, Raslan HM. Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease. Br J Biomed Sci. 2018;75(2):82\u20137. https:\/\/doi.org\/10.1080\/09674845.2017.1402404 .","journal-title":"Br J Biomed Sci"},{"issue":"14","key":"918_CR57","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.7150\/thno.23334","volume":"8","author":"E\u0141 St\u0119pie\u0144","year":"2018","unstructured":"St\u0119pie\u0144 E\u0141, Durak-Kozica M, Kami\u0144ska A, Targosz-Korecka M, Libera M, Tylko G, Opali\u0144ska A, Kapusta M, Solnica B, Georgescu A, Costa MC, Czy\u017cewska-Buczy\u0144ska A, Witkiewicz W, Ma\u0142ecki MT, Enguita FJ. Circulating ectosomes: determination of angiogenic microRNAs in type 2 diabetes. Theranostics. 2018;8(14):3874\u201390. https:\/\/doi.org\/10.7150\/thno.23334 .","journal-title":"Theranostics"},{"issue":"3","key":"918_CR58","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12265-013-9449-0","volume":"6","author":"F Rollini","year":"2013","unstructured":"Rollini F, Franchi F, Mu\u00f1iz-Lozano A, Angiolillo DJ. Platelet function profiles in patients with diabetes mellitus. J Cardiovasc Transl Res. 2013;6(3):329\u201345. https:\/\/doi.org\/10.1007\/s12265-013-9449-0 .","journal-title":"J Cardiovasc Transl Res"},{"issue":"5","key":"918_CR59","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1160\/th13-06-0476","volume":"111","author":"C Stratz","year":"2014","unstructured":"Stratz C, N\u00fchrenberg T, Fiebich BL, Amann M, Kumar A, Binder H, Hoffmann I, Valina C, Hochholzer W, Trenk D, Neumann FJ. Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression. Results from micro-array profiling in a cohort of 60 patients. Thromb Haemost. 2014;111(5):902\u201311. https:\/\/doi.org\/10.1160\/th13-06-0476 .","journal-title":"Thromb Haemost"},{"issue":"3","key":"918_CR60","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1160\/TH16-04-0322","volume":"117","author":"Z Fejes","year":"2017","unstructured":"Fejes Z, P\u00f3liska S, Czimmerer Z, K\u00e1pl\u00e1r M, Penyige A, G\u00e1l Szab\u00f3 G, Beke Debreceni I, Kunapuli SP, Kappelmayer J, Nagy B Jr. Hyperglycaemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus. Thromb Haemost. 2017;117(3):529\u201342. https:\/\/doi.org\/10.1160\/TH16-04-0322 .","journal-title":"Thromb Haemost"},{"issue":"4","key":"918_CR61","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jacc.2012.03.056","volume":"60","author":"A Zampetaki","year":"2012","unstructured":"Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, Renard JM, Mayr A, Weger S, Schett G, Shah A, Boulanger CM, Willeit J, Chowienczyk PJ, Kiechl S, Mayr M. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol. 2012;60(4):290\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2012.03.056 .","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"918_CR62","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-018-0678-z","volume":"17","author":"M Witkowski","year":"2018","unstructured":"Witkowski M, Tabaraie T, Steffens D, Friebel J, D\u00f6rner A, Skurk C, Witkowski M, Stratmann B, Tschoepe D, Landmesser U, Rauch U. MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes. Cardiovasc Diabetol. 2018;17(1):34. https:\/\/doi.org\/10.1186\/s12933-018-0678-z .","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"918_CR63","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","volume":"107","author":"S Fichtlscherer","year":"2010","unstructured":"Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, R\u00f6xe T, M\u00fcller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107(5):677\u201384. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.215566 .","journal-title":"Circ Res"},{"issue":"17","key":"918_CR64","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1038\/emboj.2012.183","volume":"31","author":"G Zhuang","year":"2012","unstructured":"Zhuang G, Wu X, Jiang Z, Kasman I, Yao J, Guan Y, et al. Tumour-secreted mir-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J. 2012;31(17):3513\u201323. https:\/\/doi.org\/10.1038\/emboj.2012.183 .","journal-title":"EMBO J"},{"issue":"7292","key":"918_CR65","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/nature08889","volume":"464","author":"S Nicoli","year":"2010","unstructured":"Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty KE, Lawson ND. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature. 2010;464(7292):1196\u2013200. https:\/\/doi.org\/10.1038\/nature08889 .","journal-title":"Nature"},{"issue":"3","key":"918_CR66","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/ncb2441","volume":"14","author":"E Hergenreider","year":"2012","unstructured":"Hergenreider E, Heydt S, Tr\u00e9guer K, Boettger T, Horrevoets AJ, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA, Dimmeler S. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012;14(3):249\u201356. https:\/\/doi.org\/10.1038\/ncb2441 .","journal-title":"Nat Cell Biol"},{"issue":"2","key":"918_CR67","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.atherosclerosis.2011.03.034","volume":"217","author":"M Vasa-Nicotera","year":"2011","unstructured":"Vasa-Nicotera M, Chen H, Tucci P, Yang AL, Saintigny G, Menghini R, Mah\u00e8 C, Agostini M, Knight RA, Melino G, Federici M. miR-146a is modulated in human endothelial cell with aging. Atherosclerosis. 2011;217(2):326\u201330. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.03.034 .","journal-title":"Atherosclerosis"},{"issue":"7","key":"918_CR68","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/emmm.201202318","volume":"5","author":"HS Cheng","year":"2013","unstructured":"Cheng HS, Sivachandran N, Lau A, Boudreau E, Zhao JL, Baltimore D, Delgado-Olguin P, Cybulsky MI, Fish JE. MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol Med. 2013;5(7):1017\u201334. https:\/\/doi.org\/10.1002\/emmm.201202318 .","journal-title":"EMBO Mol Med"},{"issue":"18","key":"918_CR69","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1161\/CIRCULATIONAHA.111.037572","volume":"124","author":"S De Rosa","year":"2011","unstructured":"De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S, Zeiher AM. Transcoronary concentration gradients of circulating microRNAs. Circulation. 2011;124(18):1936\u201344. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.037572 .","journal-title":"Circulation"},{"issue":"6","key":"918_CR70","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/ejhf.1119","volume":"20","author":"S De Rosa","year":"2018","unstructured":"De Rosa S, Eposito F, Carella C, Strangio A, Ammirati G, Sabatino J, Abbate FG, Iaconetti C, Liguori V, Pergola V, Polimeni A, Coletta S, Gareri C, Trimarco B, Stabile G, Curcio A, Indolfi C, Rapacciuolo A. Transcoronary concentration gradients of circulating microRNAs in heart failure. Eur J Heart Fail. 2018;20(6):1000\u201310. https:\/\/doi.org\/10.1002\/ejhf.1119 .","journal-title":"Eur J Heart Fail"},{"key":"918_CR71","doi-asserted-by":"publisher","first-page":"3968206","DOI":"10.1155\/2016\/3968206","volume":"2016","author":"A Carino","year":"2016","unstructured":"Carino A, De Rosa S, Sorrentino S, Polimeni A, Sabatino J, Caiazzo G, Torella D, Spaccarotella C, Mongiardo A, Strangio A, Filippis C, Indolfi C. Modulation of circulating MicroRNAs levels during the switch from clopidogrel to ticagrelor. Biomed Res Int. 2016;2016:3968206. https:\/\/doi.org\/10.1155\/2016\/3968206 .","journal-title":"Biomed Res Int"},{"issue":"17","key":"918_CR72","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gku631","volume":"42","author":"Y Ru","year":"2014","unstructured":"Ru Y, Kechris KJ, Tabakoff B, Hoffman P, Radcliffe RA, Bowler R, Mahaffey S, Rossi S, Calin GA, Bemis L, Theodorescu D. The multiMiR R package and database: integration of microRNA\u2013target interactions along with their disease and drug associations. Nucleic Acids Res. 2014;42(17):e133. https:\/\/doi.org\/10.1093\/nar\/gku631 .","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"918_CR73","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303 .","journal-title":"Genome Res"},{"issue":"8","key":"918_CR74","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck S, Spellman PT, Birney E, Huber W. Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt. Nat Protoc. 2009;4(8):1184\u201391. https:\/\/doi.org\/10.1038\/nprot.2009.97 .","journal-title":"Nat Protoc"},{"issue":"D1","key":"918_CR75","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353\u201361. https:\/\/doi.org\/10.1093\/nar\/gkw1092 .","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"918_CR76","doi-asserted-by":"publisher","first-page":"D649","DOI":"10.1093\/nar\/gkx1132","volume":"46","author":"A Fabregat","year":"2018","unstructured":"Fabregat A, Jupe S, Matthews L, Sidiropoulos K, Gillespie M, Garapati P, Haw R, Jassal B, Korninger F, May B, Milacic M, Roca CD, Rothfels K, Sevilla C, Shamovsky V, Shorser S, Varusai T, Viteri G, Weiser J, Wu G, Stein L, Hermjakob H, D\u2019Eustachio P. The reactome pathway knowledgebase. Nucleic Acids Res. 2018;46(D1):D649\u201355. https:\/\/doi.org\/10.1093\/nar\/gkx1132 .","journal-title":"Nucleic Acids Res"},{"key":"918_CR77","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.8b00702","author":"NT Doncheva","year":"2018","unstructured":"Doncheva NT, Morris J, Gorodkin J, Jensen LJ. Cytoscape stringApp: network analysis and visualization of proteomics data. J Proteome Res. 2018. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00702 .","journal-title":"J Proteome Res"},{"key":"918_CR78","doi-asserted-by":"publisher","first-page":"896362","DOI":"10.1155\/2012\/896362","volume":"2012","author":"LB Nielsen","year":"2012","unstructured":"Nielsen LB, Wang C, S\u00f8rensen K, Bang-Berthelsen CH, Hansen L, Andersen ML, Hougaard P, Juul A, Zhang CY, Pociot F, Mortensen HB. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp Diabetes Res. 2012;2012:896362. https:\/\/doi.org\/10.1155\/2012\/896362 .","journal-title":"Exp Diabetes Res"},{"issue":"4","key":"918_CR79","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00125-012-2812-x","volume":"56","author":"JW Kim","year":"2013","unstructured":"Kim JW, You YH, Jung S, Suh-Kim H, Lee IK, Cho JH, Yoon KH. miRNA-30a-5p-mediated silencing of Beta2\/NeuroD expression is an important initial event of glucotoxicity-induced beta cell dysfunction in rodent models. Diabetologia. 2013;56(4):847\u201355. https:\/\/doi.org\/10.1007\/s00125-012-2812-x .","journal-title":"Diabetologia"},{"issue":"3","key":"918_CR80","doi-asserted-by":"publisher","first-page":"e0150154","DOI":"10.1371\/journal.pone.0150154","volume":"11","author":"D Deli\u0107","year":"2016","unstructured":"Deli\u0107 D, Eisele C, Schmid R, Baum P, Wiech F, Gerl M, Zimdahl H, Pullen SS, Urquhart R. Urinary exosomal miRNA signature in type ii diabetic nephropathy patients. PLoS ONE. 2016;11(3):e0150154. https:\/\/doi.org\/10.1371\/journal.pone.0150154 .","journal-title":"PLoS ONE"},{"key":"918_CR81","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jab.2018.02.005","volume":"16","author":"J Jiang","year":"2018","unstructured":"Jiang J, Liang G, Wu Z, Mo H, You W, Wang Z, Wu K, Guo R. Naringenin alleviates high d-glucose-induced injuries through up-regulation of microRNA-30d-5p level in human AC16 cardiac cells. J Appl Biomed. 2018;16:274\u201380. https:\/\/doi.org\/10.1016\/j.jab.2018.02.005 .","journal-title":"J Appl Biomed"},{"issue":"6","key":"918_CR82","doi-asserted-by":"publisher","first-page":"31479","DOI":"10.1038\/srep31479","volume":"25","author":"AA Seyhan","year":"2016","unstructured":"Seyhan AA, Nunez Lopez YO, Xie H, Yi F, Mathews C, Pasarica M, Pratley RE. Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study. Sci Rep. 2016;25(6):31479. https:\/\/doi.org\/10.1038\/srep31479 .","journal-title":"Sci Rep"},{"issue":"8","key":"918_CR83","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3389\/fimmu.2017.01977","volume":"5","author":"S Caserta","year":"2018","unstructured":"Caserta S, Mengozzi M, Kern F, Newbury SF, Ghezzi P, Llewelyn MJ. Severity of systemic inflammatory response syndrome affects the blood levels of circulating inflammatory-relevant MicroRNAs. Front Immunol. 2018;5(8):1977. https:\/\/doi.org\/10.3389\/fimmu.2017.01977 .","journal-title":"Front Immunol"},{"key":"918_CR84","doi-asserted-by":"publisher","first-page":"28006","DOI":"10.1038\/srep28006","volume":"6","author":"S Caserta","year":"2016","unstructured":"Caserta S, Kern F, Cohen J, Drage S, Newbury SF, Llewelyn MJ. Circulating plasma microRNAs can differentiate human sepsis and systemic inflammatory response syndrome (SIRS). Sci Rep. 2016;6:28006. https:\/\/doi.org\/10.1038\/srep28006 .","journal-title":"Sci Rep"},{"issue":"21","key":"918_CR85","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1042\/CS20160305","volume":"130","author":"JB Tryggestad","year":"2016","unstructured":"Tryggestad JB, Vishwanath A, Jiang S, Mallappa A, Teague AM, Takahashi Y, Thompson DM, Chernausek SD. Influence of gestational diabetes mellitus on human umbilical vein endothelial cell miRNA. Clin Sci. 2016;130(21):1955\u201367. https:\/\/doi.org\/10.1042\/CS20160305 .","journal-title":"Clin Sci"},{"key":"918_CR86","unstructured":"Genetics Home Reference. https:\/\/ghr.nlm.nih.gov\/gene\/PRKAR1A . Accessed 3 Mar 2019."},{"issue":"10","key":"918_CR87","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1055\/s-0032-1321866","volume":"44","author":"MA Hussain","year":"2012","unstructured":"Hussain MA, Stratakis C, Kirschner L. Prkar1a in the regulation of insulin secretion. Horm Metab Res. 2012;44(10):759\u201365. https:\/\/doi.org\/10.1055\/s-0032-1321866 .","journal-title":"Horm Metab Res"},{"key":"918_CR88","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.prostaglandins.2015.05.002","volume":"120","author":"F Santilli","year":"2015","unstructured":"Santilli F, Simeone P, Liani R, Dav\u00ec G. Platelets and diabetes mellitus. Prostaglandins Other Lipid Mediat. 2015;120:28\u201339. https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.05.002 .","journal-title":"Prostaglandins Other Lipid Mediat"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0918-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-019-0918-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0918-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T20:19:42Z","timestamp":1721679582000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-019-0918-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["918"],"URL":"https:\/\/doi.org\/10.1186\/s12933-019-0918-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]},"assertion":[{"value":"14 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}